Geoffrey McCowage
- Genetics top 2%
- Glioma Diagnosis and Treatment 20
- Virus-based gene therapy research 6
- Neurology top 2%
- Neuroblastoma Research and Treatments 26
-
- Sarcoma Diagnosis and Treatment 13
- Oncology top 10%
- CAR-T cell therapy research 6
-
- Childhood Cancer Survivors' Quality of Life 10
-
- Acute Lymphoblastic Leukemia research 8
-
- Chromatin Remodeling and Cancer 5
- Co-authors
- Jennifer PeatAnn J. WoolcockCheryl M. SalomeK YanSandra D. AndersonR E SchoeffelJonathan L. FinlaySharon L. Gardner
- Journals
- Nature Medicine (1 paper)Journal of Clinical Oncology (15 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- AustraliaUnited StatesCanada
In The Last Decade
Geoffrey McCowage
78 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 113
- Genetics 451
- Neurology 447
- Pulmonary and Respiratory Medicine 682
- Oncology 300
- Pediatrics, Perinatology and Child Health 192
Countries citing papers authored by Geoffrey McCowage
This map shows the geographic impact of Geoffrey McCowage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey McCowage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey McCowage more than expected).
Fields of papers citing papers by Geoffrey McCowage
This network shows the impact of papers produced by Geoffrey McCowage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey McCowage. The network helps show where Geoffrey McCowage may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Geoffrey McCowage, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 2 | |
| 5 | 2021 | 6 | |
| 6 | 2021 | 5 | |
| 7 | 2020 | 32 | |
| 8 | 2020 | 37 | |
| 9 | 2015 | 26 | |
| 10 | 2014 | 15 | |
| 11 | 2013 | 57 | |
| 12 | Chemotherapy Regimens in Newly Diagnosed and Recurrent Ewing Sarcoma in Children and Young Adults | 2010 | 1 |
| 13 | 2008 | 155 | |
| 14 | 2008 | 107 | |
| 15 | 2008 | 11 | |
| 16 | 2008 | 45 | |
| 17 | 2005 | 21 | |
| 18 | 2003 | 113 | |
| 19 | Recombinant urate oxidase (Rasburicase) is safe and effective in managing hyperuricemia in children and adults: Results of a multi-national compassionate use trial. | 2002 | 2 |
| 20 | 1997 | 0 |
About Geoffrey McCowage
Geoffrey McCowage is a scholar working on Neurology, Genetics and Oncology, having authored 83 papers that have together received 1.8k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (26 papers), Glioma Diagnosis and Treatment (20 papers), Sarcoma Diagnosis and Treatment (13 papers), Childhood Cancer Survivors' Quality of Life (10 papers), Acute Lymphoblastic Leukemia research (8 papers), Virus-based gene therapy research (6 papers), CAR-T cell therapy research (6 papers) and Chromatin Remodeling and Cancer (5 papers). The work is most often cited by research in Genetics (451 citations), Neurology (447 citations) and Pulmonary and Respiratory Medicine (682 citations). Geoffrey McCowage has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Jennifer Peat, Ann J. Woolcock, Cheryl M. Salome, K Yan, Sandra D. Anderson, R E Schoeffel, Jonathan L. Finlay, Sharon L. Gardner, Shahab Asgharzadeh and Adam Green. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.